Ireland
--:--IST
Latest
Clinical Trials in Switzerland / NCT04926597
Recruiting Not applicable

Effect of Continued Nutritional Support at Hospital Discharge on Mortality, Frailty, Functional Outcomes and Recovery

NCT04926597 · tracked via the Priya Life Science Switzerland tracker
Sponsor
Philipp Schuetz
Phase
Not applicable
Started
2021-08-05
Last updated
2024-11-20

Condition(s) studied

Malnutrition

Investigational drug(s) / intervention(s)

nutritional supplementindividualized nutritional guidelinesgeneral nutritional information

nutritional supplement: daily use of one or more specific oral nutritional supplement with high energy/protein content (i.e., Resource Ultra, Resource 2.0 (Fibre), Resource Ultra Fruit).

individualized nutritional guidelines: nutritional plan supervised by an experienced study dietician based on the usual home nutrition with possibility to increase intake by adaptation to patient preferences, between meal snaking and food enrichment/fortification. Every 2-4 weeks phone call by unblinded study dietician to follow nutritional intervention.

general nutritional information: general information about health food behavior upon hospital discharge

Study summary

This study is to compare the sustained post-discharge nutritional support to reach individual energy and protein goals to usual care home nutrition in medical patients at nutritional risk.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Informed Consent as documented by signature * Adult (age ≥18 years), medical patients * Nutritional risk screening using the Nutritional Risk Screening (NRS): total score ≥3 points consisting of ≥1 points for impairment of the nutritional status \[weight loss \>5% in 3 month or food intake of 50-75% in the last week before hospital admission\] plus ≥1 for the severity of the disease (i.e., cancer, chronic kidney disease, chronic heart failure, COPD) and other chronic diseases according to the definition of the "National Center for Chronic Disease Prevention and Health Promotion": Chronic diseases are defined broadly as conditions that last 1 year or more and require ongoing medical attention or limit activities of daily living or both . Exclusion Criteria: * after surgery * unable to ingest oral nutrition * need for long-term nutrition, * terminal condition * acute pancreatitis or acute liver failure * patients discharged to a nursing home * patients unlikely to comply with nutritional support treatment (e.g., dementia) * COVID-Hospitalisation requiring intensive care

Primary outcome measure(s)

Trial sites (18)

FacilityCityRegionStatus
Hospital Universitari Vall Hebron de Barcelona Barcelona Spain Recruiting
Hospital Universitario de Getafe Getafe Spain Recruiting
Complejo AComplejo Asistencial Universitario de León León Spain Recruiting
Hospital U. Gregorio Marañón de Madrid Madrid Spain Recruiting
Hospital Universitario Regional de Málaga Málaga Spain Recruiting
Hospital Clínico Universitario de Valladolid Valladolid Spain Recruiting
Spital Zofingen Zofingen Canton of Aargau Completed
Spital Emmental Burgdorf Burgdorf Canton of Bern Completed
Spital Thun Thun Canton of Bern Recruiting
Spital Lachen Lachen Canton of Schwyz Recruiting
Kantonsspital Münsterlingen Münsterlingen Thurgau Recruiting
Kantonsspital Aarau, University Department of Internal Medicine Aarau Switzerland Recruiting
Bern University Hospital, Department of General Internal Medicine Bern Switzerland Completed
Kantonsspital Lucerne, Department of Internal Medicine Lucerne Switzerland Completed
Kantonsspital Sankt Gallen Sankt Gallen Switzerland Completed
Klinik Hirslanden Zürich Zurich Switzerland Completed
Stadtspital Zürich Zurich Switzerland Completed
Universitätsspital Zürich Zurich Switzerland Completed

More Philipp Schuetz trials in Switzerland

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04926597 on ClinicalTrials.gov ↗ ← All trials in Switzerland